Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) worldwide. Its pathogenesis encompasses functional alterations involving elevated intraglomerular and systemic pressure, increased activity of the renin-angiotensin system (RAS) and oxidative stress, and the eventual de...

Descripción completa

Detalles Bibliográficos
Autores principales: Giglio, Rosaria Vincenza, Patti, Angelo Maria, Rizvi, Ali Abbas, Stoian, Anca Panta, Ciaccio, Marcello, Papanas, Nikolaos, Janez, Andrej, Sonmez, Alper, Banach, Maciej, Sahebkar, Amirhossein, Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953496/
https://www.ncbi.nlm.nih.gov/pubmed/36830828
http://dx.doi.org/10.3390/biomedicines11020291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953496/
https://www.ncbi.nlm.nih.gov/pubmed/36830828
http://dx.doi.org/10.3390/biomedicines11020291

Ejemplares similares